Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Other Non-Current Liabilities (2017 - 2025)

Qiagen (QGEN) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $336.5 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 39.87% to $336.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $336.5 million through Dec 2025, up 39.87% year-over-year, with the annual reading at $336.5 million for FY2025, 39.87% up from the prior year.
  • Other Non-Current Liabilities hit $336.5 million in Q4 2025 for Qiagen, up from $240.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $336.5 million in Q4 2025 to a low of $156.7 million in Q4 2022.
  • Historically, Other Non-Current Liabilities has averaged $237.6 million across 5 years, with a median of $240.6 million in 2024.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 36.53% in 2022 and later skyrocketed 39.87% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $246.9 million in 2021, then crashed by 36.53% to $156.7 million in 2022, then soared by 32.34% to $207.4 million in 2023, then rose by 16.0% to $240.6 million in 2024, then soared by 39.87% to $336.5 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for QGEN at $336.5 million in Q4 2025, $240.6 million in Q4 2024, and $207.4 million in Q4 2023.